Gumisad, Rhisalyn C.
HRN: 21-66-74 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/11/2022
CEFUROXIME 1.5GM (VIAL)
07/11/2022
07/13/2022
IV
1.5g
Q8
S/P CS
Waiting Final Action